Skip to content

Study to assess the role of stress in etiopathogenesis of Psoriasis

A case control study on the role of manasa bhava in etiopathogenesis of Psoriasis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/12/038458
Enrollment
200
Registered
2021-12-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Sponsors

ALL INDIA INSTITUTE OF AYURVEDA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: FOR CASES: Diagnosed cases of Psoriasis who are willing to provide informed consent for the study Diagnostic criteria for cases of psoriasis 1.Well-demarcated, symmetric and erythematous plaques with overlying silvery scale 2.Auspitz sign positive 3.Koebnerâ??s Phenomenon positive 4.Candle grease sign positive FOR CONTROLS: Healthy individuals having no history of any skin disease or any other disease for the past 6 months and willing to provide informed consent for the study.

Exclusion criteria

Exclusion criteria: 1. Patients with pregnancy and lactation, uncontrolled diabetes and hypertension, any other serious systemic disorders like severe anaemia (haemoglobin % 2. Participants not willing to provide informed consent for the study.

Design outcomes

Primary

MeasureTime frame
To measure the difference in exposure of manasa bhavas in Psoriatic patients and healthy individuals and assess the etiopathological role of manasa bhava in Psoriatiic patients using a newly developed validated objective questionnaire.Timepoint: 1.5 years

Secondary

MeasureTime frame
To assess the level of anxiety using HAS Scale, Emotional component using BEIS-10, Status of disease severity using PASI Scale, status of satwa saara and Thriguna using validated scales,and the inter relationship between Satwasaaratha,Thriguna,anxiety,emotional status and disease severity in study participantsTimepoint: 2 years

Countries

India

Contacts

Public ContactDR SHALINI RAI

ALL INDIA INSTITUTE OF AYURVEDA

vd.raishalini@gmail.com9389423843

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026